AstraZeneca to Purchase Alexion for $39 Billion
LONDON - Drug maker AstraZeneca on Saturday agreed to buy Alexion, a biopharmaceutical company, for $ 39 billion in cash and stock as corporate giants return to making large acquisitions even during the pandemic.The deal comes as…